Dr. Anita Ravipati
Claim this profileThe Don and Sybil Harrington Cancer Center
Expert in Cancer
Expert in Lung Cancer
27 reported clinical trials
52 drugs studied
About Anita Ravipati
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Internal Medicine at Texas Tech University Health Sciences Center.
- Undertook a Fellowship in Hematology/Oncology at The Don and Sybil Harrington Cancer Center, part of Texas Tech University Health Sciences Center.
Experience:
- Currently practicing as a hematologist and oncologist at The Don and Sybil Harrington Cancer Center.
Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage III
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Anita Ravipati is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
More about Anita Ravipati
Clinical Trial Related1 year of experience running clinical trials · Led 27 trials as a Principal Investigator · 18 Active Clinical TrialsTreatments Anita Ravipati has experience with
- Pembrolizumab
- Nivolumab
- Cisplatin
- Oxaliplatin
- Questionnaire Administration
- Biospecimen Collection
Breakdown of trials Anita Ravipati has run
Lung Cancer
Non-Small Cell Lung Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anita Ravipati specialize in?
Anita Ravipati focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Anita Ravipati currently recruiting for clinical trials?
Yes, Anita Ravipati is currently recruiting for 16 clinical trials in Amarillo Texas. If you're interested in participating, you should apply.
Are there any treatments that Anita Ravipati has studied deeply?
Yes, Anita Ravipati has studied treatments such as Pembrolizumab, Nivolumab, Cisplatin.
What is the best way to schedule an appointment with Anita Ravipati?
Apply for one of the trials that Anita Ravipati is conducting.
What is the office address of Anita Ravipati?
The office of Anita Ravipati is located at: The Don and Sybil Harrington Cancer Center, Amarillo, Texas 79106 United States. This is the address for their practice at the The Don and Sybil Harrington Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.